Placebo Dronabinol

DRUG3 trials

Sponsors

Yale University, Massachusetts General Hospital, Montefiore Medical Center

Conditions

HealthyIntoxication AlcoholIntoxication Combined Alcohol THCIntoxication THCOpioid Use Disorder

Phase 1

Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I

CompletedNCT02811939

Yale UniversityHealthy

Start: 2016-04-07End: 2017-06-09Updated: 2022-03-02

Phase 3

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial

Not yet recruitingNCT07148206

Montefiore Medical CenterOpioid Use Disorder

Start: 2026-05-01End: 2027-12-01Target: 40Updated: 2026-02-12

Unknown Phase

Using Imaging to Assess Effects of THC on Brain Activity

CompletedNCT03655717

Massachusetts General HospitalIntoxication Alcohol, Intoxication Combined Alcohol THC, Intoxication THC

Start: 2018-11-05End: 2021-01-21Updated: 2022-07-28

Related Papers

Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy

JAMA Network Open2026-01-30

Intoxication due to Δ9-tetrahydrocannabinol is characterized by disrupted prefrontal cortex activity.

2024-05-074 citations

Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging.

2022-01-0813 citations